Reach your audience. Get results.
Rely on the experience, guidance, and superior media targeting of Business Wire for your global press release distribution.
Public RelationsMaximize the reach of your news with our press release distribution services and partnerships. Investor RelationsReach and engage investors, shareholders, analysts, and media with our complete suite of IR services and tools. Distribution & AnalyticsTarget your news, reach your audiences, and understand the impact of your press releases with our analytics reports. |
Latest News
Today is September 20, 2024.
All times in Eastern Daylight Time.
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (th... more »
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (th... more »
-
AM Best Affirms Credit Ratings for Members of Ally Insurance GroupOLDWICK, N.J.--(BUSINESS WIRE)--AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of “a” (Excellent) for the members of Ally Insurance Grou... more »
-
Playback Now Available for AM Best’s Webinar on Trends in Oil and Gas Pipeline, Wellsite and Energy Production Injury LitigationOLDWICK, N.J.--(BUSINESS WIRE)--Video playback is now available for AM Best’s complimentary webinar, titled, “Trends in Oil and Gas Pipeline, Wellsite and Energy Production Injury Litigation.” Acce... more »
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (th... more »
-
Octreotide for Chemotherapy-Induced Diarrhea Market Research 2024: Size, Regulatory Milestones, Sales Forecast, Patents, Insights 2019-2032 - Focus on US, Germany, France, Italy, Spain, UK, and Japan - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)--The "Octreotide Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. "Octreotide Market Size, Forecast, and Market ... more »
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (th... more »
-
SUNOSI for Obstructive Sleep Apnea (OSA) Market Research 2024: Size, Regulatory Milestones, Patents, Sales Forecasts, and Insights, 2019-2032 - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)--The "SUNOSI Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. "SUNOSI Market Size, Forecast, and Market Insights... more »
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (th... more »
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (th... more »
-
ChromaDex Appoints Ozan Pamir as Chief Financial OfficerLOS ANGELES--(BUSINESS WIRE)--ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, announces the appointment of Oz... more »
-
SYNAGIS Market Insights and Forecasts through 2032: Advances in Treatment and Regulatory Milestones - Focus on United States, Germany, France, Italy, Spain, United Kingdom, and Japan - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)--The "SYNAGIS Market Size, Forecast, and Market Insight - 2032" report has been added to ResearchAndMarkets.com's offering. The report on the global SYNAGIS market presents ... more »
-
LONDON--(BUSINESS WIRE)-- FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (th... more »
-
Wide Field Imaging Devices - Global Strategic Business Report to 2030 with Focus on 40+ Select Players Including Carl Zeiss Meditec, Centervue, Clarity Medical Systems and More - ResearchAndMarkets.comDUBLIN--(BUSINESS WIRE)--The "Wide Field Imaging Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for Wide Field Imaging Dev... more »
-
EnerSys Selected for $199 Million Award Negotiation to Develop State-of-the-Art Lithium-Ion Cell GigafactoryREADING, Pa.--(BUSINESS WIRE)--EnerSys (NYSE: ENS), the global leader in stored energy solutions for industrial applications, today announced that it has been selected to enter into award negotiati... more »